C M Bidwell & Associates LTD Intra Cellular Therapies, Inc. Transaction History

C M Bidwell & Associates LTD

  • $162 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 13, 2018
SELL
$17.33 - $23.4 $66,113 - $89,271
-3,815 Closed
0 $0
Q1 2018

May 11, 2018
SELL
$15.16 - $25.49 $149,553 - $251,458
-9,865 Reduced 72.11%
3,815 $80,000
Q4 2017

Feb 02, 2018
SELL
$14.27 - $16.79 $61,789 - $72,700
-4,330 Reduced 24.04%
13,680 $198,000
Q3 2017

Nov 13, 2017
BUY
$10.77 - $22.1 $193,967 - $398,021
18,010
18,010 $284,000

Others Institutions Holding ITCI

# of Institutions
379
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.87B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email